Aurrerapen terapeutikoak Parkinson gaixotasunean

1. Teresa Morera Herreras
2. Maialen Duque
3. Ainhoa Sagarduy Crepo
4. Jorge E. Ortega

Esportatu

Esportatu

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Esportatu

×

Dokumentua ezin da beste atari batetik esportatu.

Testu osoa

lock_openTestu osoa externo

DIALNET GOOGLE SCHOLAR lock_openSarbide irekia editor

Beste argitalpen batzuk: Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria

Laburpena

Parkinson’s disease (PD) is a neurodegenerative disorder related to age which prevalence is increasing, estimating that the cases will double in the next 40 years. Currently, among drugs available, L-dopa continues being the most effective therapy, but does not stop or slow down the degeneration. Moreover, its efficacy diminishes over time of treatment while mayor side effects appear, as dyskinesia. This review provides an overview of new therapeutic advances to treat PD, including serotonergic and glutamatergic drugs, pharmacokinetic optimizing pharmaceutical preparations or transcranial magnetic stimulation.

Datuen iturria: Dialnet